Study of the What the Body Does to the Drug in Subjects With Mild, Moderate, and Severe Liver Dysfunction

Clinical trial NCT02795637 · COMPLETED

Trial details

NCT number: NCT02795637
Sponsor: Sumitomo Pharma America, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Attention Deficit Hyperactivity Disorder (ADHD)Binge-Eating Disorder Disorder

Start date: 2016-05-01
Primary completion: 2016-11-01
Enrollment: 44

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.